deltatrials

Nanjing University School of Medicine Clinical Trials

Sponsors / Nanjing University School of Medicine

According to ClinicalTrials.gov, Nanjing University School of Medicine has served as lead sponsor on 36 registered trials. Across the portfolio, 4 are in recruitment, 1 are active non-recruiting, and 19 have reached completion. 3 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, business or strategic decisions. Across the portfolio, planned enrollment totals 3,725 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.

36
Total Trials
4
Recruiting
1
Other Active
19
Completed
3
Terminated / Withdrawn
3,725
Total Enrollment

Termination reasons: Recruitment67% ยท Business33%

Recent Terminations

  • NCT07108140 Phase EARLY_PHASE1 Stopped Jan 2026
    Solid Tumor
    "Portfolio prioritization"
  • NCT01451489 Phase NA Stopped Oct 2016
    FSGS
    "The recruitment of subject is very difficult"
  • NCT00885547 Phase NA Stopped May 2011
    IgA Nephropathy
    "low-rate of enrollment"

Active Trials (1 total)

Top Conditions

Top Locations